Skip to content

Strengthening the Role of the Stop TB Partnership in the Struggle Against Tuberculosis

  • Chad Cipiti

A follow up to the letter of May 3, 2011, regarding the steps being taken by the Coordinating Board to reduce the conflict of interest in the Stop TB Partnership’s relationship with the World Health Organization (WHO), improve transparency and accountability in the operations and activities of the Partnership, and strengthen the Partnership’s ability to fulfill its mandate.

Read more

Ending the Neglect of Childhood TB

  • Chad Cipiti

By Claire Wingfield It is estimated that of the nine million new cases of tuberculosis (TB) each year, one million occur among children under the age of 15. Yet advocacy for prevention, diagnosis, and treatment of TB in children has…

Read more

As with HIV Treatment, Botswana Leads the Way with TB Prevention

  • Chad Cipiti

By Javid Syed BOTUSA study strongly supports continuous preventive IPT for people with HIV Tuberculosis (TB) remains the leading cause of death among people living with HIV. The World Health Organization’s 2009 report Global Tuberculosis Control: Epidemiology, Strategy, Financing reported…

Read more

The First New Tuberculosis Drug in Decades: Promise and Challenges

  • Chad Cipiti

By Claire Wingfield After nearly 50 years, there is finally something to get excited about in tuberculosis (TB) drug development. Tibotec’s TMC207—the first compound from a novel class of TB drugs, the diarylquinolines—will likely be submitted to the U.S. Food…

Read more

Moving An Exciting New TB Diagnostic from Policy to Practice

  • Chad Cipiti

by Javid Syed On December 8, 2010 the World Health Organization (WHO) endorsed the use of the new Xpert® MTB/RIF test as the initial test offered to people suspected of having HIV-associated TB or multidrug-resistant (MDR) TB. The test, developed…

Read more
Report cover: 2011 TB R&D Report 2005-2010, 2nd Edition

2011 Report on TB Research Funding Trends

  • Chad Cipiti

This is the 2nd Edition of the Treatment Action Group and Stop TB Partnership’s 2011 report on funding trends for tuberculosis (TB) research and development (R&D) from the baseline year 2005 through 2010, the last year for which full data is available.

Read more
Report cover: 2011 Pipeline Report, Second Edition

2011 Pipeline Report

  • Chad Cipiti

HIV, Hepatitis C Virus (HCV), and Tuberculosis Drugs, Diagnostics, Vaccines, and Preventive Technologies in Development Second Edition September 2011 Written by Polly Clayden, Simon Collins, Mark Harrington, Richard Jefferys, Tracy Swan, Javid Syed, and Claire Wingfield with a a contribution…

Read more
Back To Top